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1139-13 Clinical Performance of the WaveletTM Automatic 
Electrogram Template Collection Algorithm 
Steven J. Compton, Jay Merrill, Paul Dorian, Jian Cao, Duo Zhou. Alaska Heart Institute, 
Anchorage, AK, Medtronic, Inc., Minneapolis, MN 
Background: Electrogram morphology (EGM) analysis may improve arrhythmia discrim- 
ination in implantable cardiovertar-defibrillators, but the EGM may change with lead mat- 
uration, drugs or disease progression. We evaluated a novel 3.stage automatic algorithm 
that collects and confirms the EGM template and then continuously assesses the need 
for template updating. 
Methods: The new algorithm first collects a template from the patient’s non-paced, slow 
rhythm and screens out premature ventricular contractions. Template confirmation 
requires that > 70 of 100 non-paced beats match the template before it is activated for 
VTISVT discrimination (> 12 minutes). Matching of the template and intrinsic EGM is per- 
formed using match scores computed using a Wavelet transform-based method 
described previously. After template activation, a continuous quality check triggers the 
collection of a new template when fewer than 70 of 100 non-paced beats match the tern- 
plate (> 8 hours). This new algorithm was studied in 50 patients implanted with the 
Medtronic Marquis VR ICD. Automatic templates ware compared with the patient’s real- 
time intrinsic EGM using Wavelet match score evaluation at pre-hospital discharge 
(PHD) and up to 4 weeks post implant. 
Results: All 50 patients had at least one automatic template created and 17 (34%) of 
those had template updating. The median time to create the first automatic template was 
73.6 minutes. The median number of automatic templates was 3 per patient (range 2 - 
33). Of the 146 automatic templates compared to intrinsic rhythm, 139 (95.2%) had a 
median match score t 70% (2 to 25 beats). Intrinsic rhythm at one month had signifi- 
cantly higher match scores with automatic templates (88.4*8.2%) than with manual tem- 
plates generated at PHD (83.4*11.3%) (P ~0.05) or with automatic templates created at 
,implant (81.9*10.6%) (P<O.OOl). 
Conclusion: Changes in EGM morphology over time were observed, thus documenting 
the need for automatic template updating. The new automatic template collection algo- 
rithm operated property in all patients. 
1139-14 Smoking Is Associated With Increased Risk of Shocks 
After Cardioverter Defibrillator Implantation (TOVA 
Study) 
Jaqmest P. Sinqh, Murray A. Mittleman, Paul J. Wang, Jennifer C. Merlan, David Rich, 
James E. Muller, Jeremy N. Ruskin, Christine M. Albert, Massachusetts General 
Hospital, Boston, MA, Beth Israel Deaconess Medical Center, Boston, MA 
Background: Although smoking is associated with increased incidence of coronary 
artery disease, there is a paucity of data examining its influence on the occurrence of 
ventricular tachyarrhythmias. Methods and Results: As a part of the TOVA (Triggers of 
Ventricular Arrhythmias) study, we prospectively analyzed the relationship between 
smoking status at baseline and subsequent risk of internal cardioverter defibrillator (ICD) 
discharges for ventricular tachycarditiventricular fibrillation (VTNF) among 861 ICD 
patients (mean age, 63 years). Over a mean follow up period of 421 days, 53 patients 
received ICD discharges for VTNF. In univariate Cox models, smokers (n=265) had a 
2.6 fold increased risk of ICD discharge for VTNF (P=O.O2), and this elevation in risk was 
essentially unchanged in multivariate models that controlled for age, sex, ejection frac- 
tion, history of prior ICD therapy and diabetes, (relative risk (RR) 2.6; 95% confidence 
interval (Cl), 1.2 to 5.9). Further control for obesity, hypertension, beta-blocker use, 
angina. electrophysiologic study results and indications for implantation did not signifi- 
cantly alter these results. Both past smokers (n=l93, RR 2.6, Cl 1.1-5.9) and current 
smokers (n=72, RR 2.9, Cl 1.0-8.8) were at an elevated risk of subsequent VTNF, 
although power was limited to detect risk differences between current and past smokers 
Conclusion: These prospective data suggest that smoking is a significant risk factor for 
ventricular arrhythmias in susceptible patients. Further prospective study is needed to 
assess whether smoking cessation will reduce the incidence of VTNF in ICD patients. 
1139-15 The Increase in Women Receiving Implantable 
Cardioverter Defibrillators: Changes in Characteristics 
or Indications? 
Ralph J. Vsrdino, Joseph Poku, Andrea M. Russo, Dusan 2. Kocovic, Henry H. Hsia, 
David J. Callans. Edward P. Gerstenfeld, Matthew B. Hillis, David Lin, John F. Beshai, 
Francis E. Marchlinski, University of Pennsylvania Health System, Philadelphia, PA 
Greater numbers of women are undergoing invasive cardiovascular procedures as indi- 
cations have evolved. We sought to characterize the changes in women undergolng 
insertion of implantable cardioverter defibrillators (ICDs) over the past 15 years. We 
reviewed our records in 233 wmen of 980 total patients undergoing initial ICD implanta- 
tion from the years 1986 to 2000. For the purpose of analysis, implant dates were divided 
into 3 time periods. Patient characteristics and indications for ICDs were indentified and 
compared. (See chart) 
We conclude that patient characteristics (mean age, ejection fraction and disease pro- 
cess) of wmen patients undergoing ICD placement has not significantly changed wer 
the past 15 years. However, wcmen comprise a greater portion of ICD’s patient implants. 
and undergo ICD implantation more often for arrhythmic risk or for symptoms presumed 
to be arrhythmic than earlier days of ICD implantation. 
total# wmlen 
% of total implants 
mean woman age 
mean % EF 
% CAD 
% VT or VF 
% syncope 
% prophylaxis 
86_90 91_95 96_00 g 
31 34 178 
18.8 20.5 27.6 CO.05 
56 58 61 “.s. 
33 31 34 “.S. 
37 50 38 “.S. 
87 77 38 
13 23 32 
0 0 30 
1139-16 A Moderate Scan Antitachycardia Pacing Protocol Is 
Superior to Burst or Ramp Stimulation 
Rainer Schreof, Hagen Gross, Marcus Leibig, Karl The&n, Medical Clinic of the 
University of Munich - Innenstadt, Munich, Germany 
Extensive testing of anti-tachycardia pacing (ATP) is outdated because the clinically rele- 
vant arrhythmia often is not inducible. Nowadays we usually program a standard stimula- 
tion sequence. 
The aim of our randomized prospective rxss~ver study was to compare moderate burst, 
scan and ramp protocols to define a first standard programmlng with a high success and 
low complication rate. 
36 patients with a first implantation of an ICD were randomized to either a burst (coupling 
interval and cycle length El%, 4 extra stimuli (ES) increasing to 7 ES), a scan (in addition 
a scan of 8 ms) or a ramp protocol (in addition a ramp of 8 ms). The recurrence of VT and 
the effectiveness of the ATP was registered by the device’s Halter. Double crossover of 
the stimulation modalities was performed after nine and eighteen months. Statistical 
analysis was periormed by SAS multivariate test. 
Results: All patients completed the twenty seven months follow-up. We registered 202 
episodes of sustained VT. 74 episodes were treated by a burst of which 63 were termi- 
nated by the first stimulation (85%), 7 were terminated by furiher stimulation. Four epi- 
sodes needed a cardioversion after ineffective ATP. None of the patients showed 
tachycardia rate acceleration. 67 episodes were treated by a scan ATP with a first suc- 
cess rate of 88% (59 episodes). 8 needed further stimulation to be terminated but none of 
the patients was accelerated or needed a cardioversion because of ineffectiveness of the 
ATP. 61 episodes were treated by a ramp protocol. First success rate was 69% (42 epi- 
sodes), acceleration occurred in 17 of which 6 were only terminated by a cardioversion. 
Two episodes needed a cardioversion because of ineffective pacing without prior accel- 
eration through the ATP. Over all effectiveness of a scan stimulation was significantly 
higher than a burst ( p < 0.005) or a ramp protocol (p < 0.001). 
Conclusion: Moderate ATP with a coupling interval and a cycle length of 81% and a scan 
of 8 ms proved to be significantly rnwe effective and less risky than comparable burst or 
ramp protocols. 
1139-17 The Circadian Variation of Atrial Defibrillation 
Thresholds 
Andrew R. Mitchell, Eduardo N. Warman, Katie Schaaf, Neil Sulke, Eastbourne General 
Hospital, Eastbourne, United Kingdom, Medtronic Inc., Minneapolis, MN 
For the Worldwide Jewel AF-On/y /nvestigators 
Background: A circadian variation exists for ventricular defibrillation thresholds (DFTs) 
with a morning peak and a corresponding decrease in therapy success rates. Such a 
variation in atrial DFTs may have implications for the timing of internal and external car- 
dioversion of atrial arrhythmias. 
Methods: Data was collected as part of the worldwide Jewel AF study. Patients were 
selected if they had recurrent persistent AF and no history of ventricular arrhythmias. The 
atrial DFT was assessed at implantation of the device with a step-up protocol and was 
defined as the lowest energy to restore sinus rhythm. The atrial DFT was compared with 
time of testing for 100 patients (age 63.0*11.7, 74% male, EF 49.6e17.8, left atrial diam- 
eter 46+9mm). 
ResultsThe mean atrial DFT was 6.3*4&l. Analysis of the atrial DFT for the most com- 
monly tested lead configuration (right atrium to coronary sinus) in 56 patients, the DFT 
for the morning (3.3+1.5J) was significantly lower than the DFT measured in the after- 
nwn (5.8*3.4J, p<O.Ol) and the DFT in the evening (7.4t5.9J, p=O.Ol). 
